hotspot -WSS

hotspot

author：fashion 2025-09-06 03:17:17 - browse：5322

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Bristol Myers buys into radiopharmaceuticals with RayzeBio

focus

entertainment

WSS

Inside the rise of 'mukbang' eating videos

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Can sheer will power keep patients alive in their dying hours?

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Senate panel passes drug pricing bills, but drops one PBM reform

Millions may soon lose Medicaid when they don't have to

focus

hotspot

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: The latest on Moderna, Apellis, and Merck

At least 13 dead in Texas as scorching temps continue

A public health expert passes on football's full body collisions for youths

DIEP, the 'gold standard' of breast reconstruction, is under threat

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Dobbs anniversary: the lost opportunity of abortion as health care

SEC charges former device maker CEO with $41 million fraud

Medical leaders decry Supreme Court decision on affirmative action

Inside the rise of 'mukbang' eating videos

knowledge

A public health expert passes on football's full body collisions for youths

Xenotransplantation trials will require adjusting expectations, experts say

Reanimated hearts work just as well for transplants, study finds

Violet CEO on training clinicians to promote more inclusive care

David Ricks of Eli Lilly: best biopharma CEO of 2023

How to keep neuroscience’s past racism from being its future

focus

entertainment

entertainment

hotspot